DK0909184T3 - Målrettet lægemiddelindgivelse ved anvendelse af sulfonamidderivater - Google Patents
Målrettet lægemiddelindgivelse ved anvendelse af sulfonamidderivaterInfo
- Publication number
- DK0909184T3 DK0909184T3 DK97931327T DK97931327T DK0909184T3 DK 0909184 T3 DK0909184 T3 DK 0909184T3 DK 97931327 T DK97931327 T DK 97931327T DK 97931327 T DK97931327 T DK 97931327T DK 0909184 T3 DK0909184 T3 DK 0909184T3
- Authority
- DK
- Denmark
- Prior art keywords
- glutathione
- sulfonamide
- gsh
- gst
- derivatized
- Prior art date
Links
- 229940124530 sulfonamide Drugs 0.000 title abstract 4
- 238000001647 drug administration Methods 0.000 title 1
- 150000003456 sulfonamides Chemical class 0.000 title 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract 6
- 102000005720 Glutathione transferase Human genes 0.000 abstract 4
- 108010070675 Glutathione transferase Proteins 0.000 abstract 4
- 108010024636 Glutathione Proteins 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 239000012039 electrophile Substances 0.000 abstract 2
- 229960003180 glutathione Drugs 0.000 abstract 2
- -1 2,4 dinitrophenylsulfonyl groups Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 125000000565 sulfonamide group Chemical group 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Virology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2248996P | 1996-07-03 | 1996-07-03 | |
| PCT/US1997/010817 WO1998000173A2 (en) | 1996-07-03 | 1997-07-01 | Targeted drug delivery using sulfonamide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0909184T3 true DK0909184T3 (da) | 2003-12-22 |
Family
ID=21809866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97931327T DK0909184T3 (da) | 1996-07-03 | 1997-07-01 | Målrettet lægemiddelindgivelse ved anvendelse af sulfonamidderivater |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0909184B1 (da) |
| JP (1) | JP2001505533A (da) |
| AT (1) | ATE249842T1 (da) |
| AU (1) | AU3498397A (da) |
| DE (1) | DE69724964T2 (da) |
| DK (1) | DK0909184T3 (da) |
| ES (1) | ES2208923T3 (da) |
| PT (1) | PT909184E (da) |
| WO (1) | WO1998000173A2 (da) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6326507B1 (en) | 1998-06-19 | 2001-12-04 | Trustees Of Dartmouth College | Therapeutic compounds and methods of use |
| AUPQ014699A0 (en) * | 1999-05-04 | 1999-05-27 | Access Pharmaceuticals Australia Pty Limited | Amplification of folate-mediated targeting to tumor cells using nanoparticles |
| US6511962B1 (en) | 2000-07-17 | 2003-01-28 | Micrologix Biotech Inc. | Derivatives of laspartomycin and preparation and use thereof |
| US6737403B2 (en) | 2000-07-17 | 2004-05-18 | Micrologix Biotech Inc. | Derivatives of laspartomycin and preparation and use thereof |
| US6750199B2 (en) | 2000-07-17 | 2004-06-15 | Micrologix Biotech Inc. | Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
| WO2002005837A1 (en) * | 2000-07-17 | 2002-01-24 | Intrabiotics Pharmaceuticals, Inc. | Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
| US7435755B2 (en) | 2000-11-28 | 2008-10-14 | The Trustees Of Dartmouth College | CDDO-compounds and combination therapies thereof |
| US7176237B2 (en) | 2002-01-15 | 2007-02-13 | The Trustees Of Dartmouth College | Tricyclic-bis-enone derivatives and methods of use thereof |
| WO2004041203A2 (en) | 2002-11-04 | 2004-05-21 | Xenoport, Inc. | Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
| DE10347863A1 (de) * | 2003-10-10 | 2005-05-04 | Oxeno Olefinchemie Gmbh | Verfahren zur Herstellung von Benzoesäureestern |
| EP2094651A1 (en) | 2006-11-17 | 2009-09-02 | Trustees Of Dartmouth College | Synthesis and biological activities of new tricyclic-bis-enones (tbes) |
| US8921340B2 (en) | 2006-11-17 | 2014-12-30 | Trustees Of Dartmouth College | Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions |
| US8299046B2 (en) | 2006-11-17 | 2012-10-30 | Trustees Of Dartmouth College | Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth |
| BRPI0907423A2 (pt) | 2008-01-11 | 2020-10-27 | Reata Pharmaceuticals, Inc. | composto triterpenoide sintético para uso em um método de melhoria da função renal em um indivíduo, e uso do referido composto |
| WO2009146218A2 (en) | 2008-04-18 | 2009-12-03 | Reata Pharmaceuticals, Inc. | Compounds including an anti-inflammatory pharmacore and methods of use |
| KR101713140B1 (ko) | 2008-04-18 | 2017-03-08 | 리타 파마슈티컬스 잉크. | Ｃ-환에서 포화된 산화방지성 염증 조절제 올레아놀산 유도체 |
| US8071632B2 (en) | 2008-04-18 | 2011-12-06 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: novel derivatives of oleanolic acid |
| MX2010011439A (es) | 2008-04-18 | 2011-01-25 | Reata Pharmaceuticals Inc | Moduladores de inflamacion antioxidantes: derivados del acido oleanolico homologacion c-17. |
| JP5529851B2 (ja) | 2008-04-18 | 2014-06-25 | リアタ ファーマシューティカルズ インコーポレイテッド | 抗酸化炎症モジュレーター：ｃ−１７においてアミノ改変およびその他の改変を加えたオレアノール酸誘導体 |
| CN108686203A (zh) | 2012-04-04 | 2018-10-23 | 哈洛齐梅公司 | 使用抗透明质酸剂和肿瘤靶向紫杉烷的组合疗法 |
| US8921419B2 (en) | 2012-05-08 | 2014-12-30 | Trustees Of Dartmouth College | Triterpenoids and compositions containing the same |
| US20190351031A1 (en) | 2018-05-16 | 2019-11-21 | Halozyme, Inc. | Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20 |
| WO2020242218A1 (ko) * | 2019-05-28 | 2020-12-03 | 울산과학기술원 | 글루타치온-ｓ-전이효소 및 표적 세포 또는 표적 단백질 결합능을 갖는 단백질을 포함하는 글루타치온 전구체 약물의 전달체 및 이의 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8705477D0 (en) * | 1987-03-09 | 1987-04-15 | Carlton Med Prod | Drug delivery systems |
| FR2645537B1 (fr) * | 1989-04-05 | 1994-03-04 | Fabre Medicament Pierre | Nouveaux sulfonamides derives d'acides benzocycliques ou benzoheterocycliques, leur preparation et leur application en therapeutique |
| JPH07502970A (ja) * | 1990-06-01 | 1995-03-30 | ザ・デュポン・メルク・ファーマシュウティカル・カンパニー | １，４―ジアミノ―２，３―ジヒドロキシブタン類 |
| ZA938019B (en) * | 1992-11-13 | 1995-04-28 | Upjohn Co | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
| US5882941A (en) * | 1994-05-04 | 1999-03-16 | Massachusette Institute Of Technology | Programmable genotoxic agents and uses therefor |
| IL129871A (en) * | 1994-05-06 | 2003-11-23 | Pharmacia & Upjohn Inc | Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections |
-
1997
- 1997-07-01 PT PT97931327T patent/PT909184E/pt unknown
- 1997-07-01 WO PCT/US1997/010817 patent/WO1998000173A2/en not_active Ceased
- 1997-07-01 AU AU34983/97A patent/AU3498397A/en not_active Abandoned
- 1997-07-01 AT AT97931327T patent/ATE249842T1/de not_active IP Right Cessation
- 1997-07-01 JP JP50422098A patent/JP2001505533A/ja not_active Withdrawn
- 1997-07-01 EP EP97931327A patent/EP0909184B1/en not_active Expired - Lifetime
- 1997-07-01 DK DK97931327T patent/DK0909184T3/da active
- 1997-07-01 DE DE69724964T patent/DE69724964T2/de not_active Expired - Fee Related
- 1997-07-01 ES ES97931327T patent/ES2208923T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU3498397A (en) | 1998-01-21 |
| DE69724964D1 (de) | 2003-10-23 |
| PT909184E (pt) | 2004-02-27 |
| ES2208923T3 (es) | 2004-06-16 |
| WO1998000173A2 (en) | 1998-01-08 |
| ATE249842T1 (de) | 2003-10-15 |
| EP0909184B1 (en) | 2003-09-17 |
| EP0909184A2 (en) | 1999-04-21 |
| WO1998000173A3 (en) | 1998-05-07 |
| JP2001505533A (ja) | 2001-04-24 |
| DE69724964T2 (de) | 2004-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0909184T3 (da) | Målrettet lægemiddelindgivelse ved anvendelse af sulfonamidderivater | |
| AR065404A1 (es) | Conjugados farmaco-ligando, los que se unen a citotoxinas potentes, composicion farmaceutica que los contienen y su uso para retardar o detener el crecimiento de un tumor en un mamifero | |
| AR067837A1 (es) | Conjugados de farmaco-ligando y sustratos farmaco-escindibles, composiciones que los contienen; utiles en el tratamiento de tumores y cancer | |
| ID25979A (id) | TURUNAN-TURUNAN KOMTOTESIN (Pecahan dari P-963785) | |
| ES2196527T3 (es) | Derivados de 11,15-o-dialquilprostaglandina e, su procedimiento de produccion y medicamentos que incluyen estos como principio activo. | |
| PA8472301A1 (es) | Derivados de isotiazol utiles como agentes anticancerosos | |
| DK1033981T3 (da) | Formuleringer og fremgangsmåder til nedsættelse af antineoplastiske midlers toksicitet | |
| ATE507845T1 (de) | Polyacetal-arzneimittelkonjugate als freisetzungssystem | |
| BR0112104A (pt) | Processos para tratamento de doenças reumáticas usando uma molécula de ctla4 solúvel | |
| DE59707812D1 (de) | Opioidantagonisthaltige galenische formulierung | |
| DE60207831D1 (de) | Thiol-modifizierte hyaluronan-derivate | |
| GT200300193A (es) | Formulaciones que comprenden un compuesto de indolinona | |
| DE69635996D1 (de) | Pharmazeutische zusammensetzungen mit hydroximsäurederivaten | |
| TR200001906T2 (tr) | Koks-Inhibitörleri olarak 2,3-ikameli indol bileşikleri. | |
| AU2003259382A1 (en) | Enzyme activated self-immolative n-substituted nitrogen mustard prodrugs | |
| AR014964A1 (es) | Derivados de indol, composiciones farmaceuticas que los contienen, agentes para reducir la presion intraocular, tratar glaucoma e hipertension ocular, usosen la fabricacion de composiciones farmaceuticas y procedimiento de fabricacion de dichas composiciones | |
| BR0212353A (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BR0308071A (pt) | Inibidores da protéina farnesil transferase como agentes antitumores | |
| BR0104358A (pt) | Formulações de taxana tendo solubilidade aperfeiçoada | |
| DE69931378D1 (de) | Chinazolin derivate und therapeutische verwendungen davon | |
| ATE331730T1 (de) | Neue depsipeptid-verbindung | |
| BR0110874A (pt) | Derivados de sulfonamida | |
| NZ510938A (en) | Phospholipid derivatives of non-steroidal anti-inflammatory drugs | |
| SV2002000211A (es) | Derivados de higromicina ref. pc10726abcz/bb | |
| HN2001000119A (es) | S-metil-dihidro -ziprasidona para el tratamiento de trastornos psiquiatricos y oculares. |